For example, 11% of human HCCs show concomitant CTNNB1 mutations and Met overexpression/activation, and their co-expression in murine liver in the Met–β-catenin model leads to clinically relevant HCC [63,71]. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.